InvestSMART

MGC Pharmaceuticals Ltd (ASX: MXC) - Announcements

Current share price for MXC : $0.420 0.01 (2.44%)+

ASX company news and announcements for MGC Pharmaceuticals Ltd (MXC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All MGC Pharmaceuticals Ltd (MXC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than MGC Pharmaceuticals Ltd (MXC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for MGC Pharmaceuticals Ltd (MXC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$18 Change of Director's Interest Notice- Appx 3Y Nativ Segev 25 Feb 2019 2:10PM $0.039 $0.420 risen by 976.92%
$18 Appendix 3B - Expiry of Performance Shares 22 Feb 2019 8:18AM $0.040 $0.420 risen by 950%
$18 Expiration of 100m Performance Shares 21 Feb 2019 9:27AM $0.039 $0.420 risen by 976.92%
$18 Change of Director's Interest Notice- Appx 3Y Roby Zomer 11 Feb 2019 11:32AM $0.040 $0.420 risen by 950%
$18 Change of Director's Interest Notice- Appx 3Y Nativ Segev 11 Feb 2019 11:31AM $0.040 $0.420 risen by 950%
$18 Change of Director's Interest Notice- Appx 3Y Brett Mitchell 11 Feb 2019 11:29AM $0.039 $0.420 risen by 976.92%
$18 MXC Botanical Update 1 Feb 2019 9:38AM $0.040 $0.420 risen by 950%
$18 Completion of MGC Derma Sale to CannaGlobal 29 Jan 2019 9:41AM $0.040 $0.420 risen by 950%
$18 Major Regulatory Milestones Achieved for Pharma Business 22 Jan 2019 9:57AM $0.040 $0.420 risen by 950%
$18 December Quarterly Activity and Cashflow Report 18 Jan 2019 12:21PM $0.042 $0.420 risen by 900%
$18 First CannEpil Product arrives in Australia 24 Dec 2018 9:38AM $0.033 $0.420 risen by 1,172.73%
$18 MXC commences trading on the US OTCQB Venture Market 19 Dec 2018 9:37AM $0.038 $0.420 risen by 1,005.26%
$18 Release of Restricted Securities 5 Dec 2018 3:32PM $0.042 $0.420 risen by 900%
$18 MGC Derma - CannaGlobal Transaction Update 3 Dec 2018 8:28AM $0.042 $0.420 risen by 900%
$18 Chairman's Address - 2018 AGM 22 Nov 2018 6:34PM $0.041 $0.420 risen by 924.39%
$18 Results of Annual General Meeting 22 Nov 2018 3:00PM $0.041 $0.420 risen by 924.39%
$18 AGM 2018 Webinar Details 20 Nov 2018 5:08PM $0.041 $0.420 risen by 924.39%
$18 Legal Proceedings Commenced against Varm Cosmo 15 Nov 2018 9:37AM $0.043 $0.420 risen by 876.74%
$18 Reinstatement to Official Quotation 13 Nov 2018 11:56AM $0.051 $0.420 risen by 723.53%
$18 Definitive Agreement Signed for Sale of MGC Derma 13 Nov 2018 11:55AM $0.051 $0.420 risen by 723.53%
$18 Voluntary Suspension Extension 7 Nov 2018 9:17AM $0.051 $0.420 risen by 723.53%
$18 Suspension from Official Quotation 5 Nov 2018 9:23AM $0.051 $0.420 risen by 723.53%
$18 Trading Halt 1 Nov 2018 9:37AM $0.051 $0.420 risen by 723.53%
$18 Appendix 4G and Corporate Governance Statement 31 Oct 2018 5:44PM $0.051 $0.420 risen by 723.53%
$18 Annual Report 2018 31 Oct 2018 5:41PM $0.051 $0.420 risen by 723.53%

576 - 600 of 818 results

Page 24 of 33

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.